COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS: CLINICAL CORE

流感疫苗合作创新中心：临床核心

• 批准号: 10523259
• 负责人: KATHLEEN NEUZIL
• 金额: $ 290.71万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-16 至 2025-08-20
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10523259
• 关键词: Clinical Trials; Development; Ethics; Human; National Institute of Allergy and Infectious Disease; Phase I Clinical Trials; System; Vaccines; clinical center; design; influenza virus vaccine; innovation; sound; universal influenza vaccine

To design, implement and manage ethical and statistically sound clinical trials and human challenge studies for influenza vaccines, vaccine components and delivery systems developed by the NIAID Collaborative Influenza Vaccine Innovation Centers.

设计，实施和管理由NIAID流感疫苗创新合作中心开发的流感疫苗，疫苗成分和输送系统的伦理和统计上合理的临床试验和人体挑战研究。